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A B S T R A C T
Lung cancer screening is a relatively new screening option. Inequalities related to screening behavior have been
documented in other types of cancer screening. Because stage at presentation drives mortality in lung cancer, it
is critical to understand factors that inﬂuence screening behavior in lung cancer screening in order to intervene.
However, we must ﬁrst understand where disparities exist in lung cancer screening participation in order to
eﬀectively guide intervention eﬀorts. Therefore, the purpose of this study was to determine the association of
sociodemographic (including key disparity-related variables) and knowledge with lung cancer screening beha-
vior. This cross-sectional, descriptive study used survey methodology to collect data from 438 screening-eligible
individuals in the state of Indiana between January and February 2017 and measured sociodemographic vari-
ables and knowledge about lung cancer and screening. Key sociodemographic and health status characteristics
associated with screening behavior included race, geographic area of residence, income, health insurance, and
family history of lung cancer. Of the variables generally reﬂective of disparities, key diﬀerences were noted by
race and geographic area of residence with total knowledge scores as well as screening behavior, respectively.
Results indicate key diﬀerences in race and geographic area of residence that may perpetuate screening behavior
disparities. We have a unique opportunity at this early implementation stage in lung cancer screening to learn
what variables inﬂuence screening behavior from our target patient population. This knowledge can be used to
design equitable patient outreach programs, meaningful, tailored patient engagement materials, and eﬀective
patient-clinician decision support tools.
1. Introduction
Lung cancer is the leading cause of all cancer-related deaths in the
U.S. with> 158,000 people dying annually; approximately 4000 of
those deaths occur among Indiana residents (American Cancer Society,
2017; Indiana Cancer Consortium, 2015). Cancer screening has the
potential to save lives by identifying lung cancer early when individuals
are asymptomatic and has been associated with decreased mortality
rates in those at high-risk (Aberle et al., 2011). Individuals qualify for
lung cancer screening if they are aged 55 to 80, are a current smoker or
former smoker who has quit within the past 15 years, and have at least
a 30 pack-year tobacco smoking history (Moyer, 2014). Lung cancer
screening is performed with low-dose computed tomography (LDCT) of
the chest and screening guidelines were issued in 2013 with a Grade B
recommendation by the U. S. Preventive Services Task Force (USPSTF)
(Moyer, 2014). Further, lung cancer screening is a preventive health
service with a zero out-of-pocket copay under the Aﬀordable Care Act
and a covered preventive service by the Centers for Medicare and
Medicaid Services (CMS) for screening-eligible beneﬁciaries (United
States Preventive Services Task Force Lung Cancer Screening
Guidelines, 2013).
Inequalities related to screening behavior have been documented in
established cancer screening programs such as breast and colorectal
cancer screening (Liss & Baker, 2014; Chowdhury et al., 2016; Miranda
et al., 2011). Historically, the availability of a new screening test in-
creases race and socioeconomic disparities in cancer stage at diagnosis
and mortality. Once the screening test becomes standard of care and is
in widespread use, disparities tend to decrease but remain (Link &
Phelan, 1996; Phelan et al., 2004). This is evidenced at present by racial
disparities noted in breast and colorectal cancers for which screening
tests have long been available (American Cancer Society, 2017). Lung
cancer screening is a relatively new screening option. Of the 6.8 million
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Americans who currently qualify for lung cancer screening, < 4% have
been screened (Jemal & Fedewa, 2017). Identifying factors associated
with screening behavior is important in order to proactively address
screening disparities. In the National Lung Screening Trial on which the
lung cancer screening guideline is based, LDCT of the chest reduced
lung cancer mortality more in Black participants compared to their
White counterparts (hazard ratio 0.61 vs. 0.86) respectively. (Tanner
NT et al., 2015) In order for this beneﬁt to be translated to the real
world setting, eﬀective screening interventions that target engagement
of screening-eligible individuals as well as address race-relevant issues
in lung cancer screening must be implemented. However, we must ﬁrst
understand where disparities exist in relation to lung cancer screening
participation in order to guide intervention eﬀorts. Having a baseline
understanding of variables associated with lung cancer screening be-
havior as well as potential disparities is a critical prerequisite to
proactively addressing equitable implementation of lung cancer
screening.
Little is known about the relationship of sociodemographic and
health status characteristics, including key variables generally re-
ﬂective of disparities (i.e., race, gender, and geographic area of re-
sidence), and their association with lung cancer screening behavior.
Because stage at presentation drives mortality in lung cancer (American
Cancer Society, 2017), screening high-risk smokers is critical for early
detection and subsequent treatment at earlier stages and has the po-
tential to decrease mortality. Therefore, the purpose of this paper is to
determine whether sociodemographic variables including key disparity-
related variables (race, gender, and geographic area of residence) and
knowledge are associated with lung cancer screening behavior in
screening-eligible individuals in the state of Indiana. Research ques-
tions include:
1) What sociodemographic and health status characteristics (including
key disparity variables) are associated with lung cancer screening
behavior?
2) Does knowledge of lung cancer risk and screening diﬀer by key
disparity variables or sociodemographic characteristics?
3) Do sociodemographic and health status characteristics that are as-
sociated with lung cancer screening behavior depend on race,
gender, or geographic area of residence?
2. Methods
2.1. Study design, sample, and data collection
A cross-sectional study was conducted using survey methods.
Participants were recruited in the state of Indiana from January to
February 2017 using two primary community-based recruitment
methods, Facebook targeted advertisement and in-person recruitment
eﬀorts at four local community senior centers. Power analysis indicated
that 300 participants were needed to detect an odds ratio of 2.64 or
higher when analyzing categorical variables and an eﬀect size of 0.60
or higher when analyzing continuous variables. Inclusion criteria mir-
rored USPSTF lung cancer screening eligibility criteria: 1) age 55 to
80 years; 2) minimum 30-pack-year tobacco smoking history; 3) current
smoker or former smoker who quit within the past 15 years; and 4) not
diagnosed with lung cancer.
Institutional review board approval was obtained from Indiana
University prior to participant recruitment. Data were collected via a
one-time, web-based survey using REDCap (Research Electronic Data
Capture). For participants recruited in-person who did not wish to
complete the survey online, a paper copy of the survey was provided
(n=52).
2.2. Measures
Guided by the Conceptual Model on Lung Cancer Screening
Participation (Carter-Harris et al., 2016), data were collected using a
compilation of items and scales to assess lung cancer screening beha-
vior, sociodemographic and health status characteristics (age, gender,
race, geographic area of residence, income, education, insurance status,
smoking status, and family history of lung cancer), and knowledge of
lung cancer and screening. Geographic area of residence was categor-
ized using address and zip code data to classify participants as residing
in urban, suburban, or rural areas.
2.3. Lung cancer screening behavior
The stage theory, Precaution Adoption Process Model (PAPM) (“The
Precaution Adoption Process Model” by Neil D. Weinstein, Peter M.
Sandman, and Susan J. Blalock, et al., 2008), was used to create an
algorithm of questions to assess the primary outcome variable of an
individuals' stage of adoption for lung screening behavior, which in-
cluded intent to screen for lung cancer in the next six months. The
PAPM involves seven stages ranging from Stage 1 (unaware) to Stage 7
(maintenance) (“The Precaution Adoption Process Model” by Neil D.
Weinstein, Peter M. Sandman, and Susan J. Blalock, et al., 2008).
“Screeners” are deﬁned in this study as those individuals who indicated
they either intended to screen for lung cancer (Stage 5), had recently
completed lung cancer screening (Stage 6), or were screening annually
(Stage 7).
3. Data analyses
Data were exported from REDCap into SAS version 9.4 (SAS
Institute, Cary, North Carolina) and cleaned by examining frequency
tables and removing invalid data. Data were evaluated for outliers and
to determine if the data were normally distributed. Missing, multiple
responses, “inapplicable”, and “don't know” answers were recoded as
missing for analytic purposes. Due to the low frequencies of non-Black
and non-White races (n=16), these were omitted in order to prevent
spurious results. Two participants did not answer the PAPM and were
also removed from analysis. For research question one, data were
analyzed comparing screened and non-screened groups using the
Pearson Chi-Square test to compare unordered categorical variables and
the 1df Mantel-Haenszel Chi-Square test of trend to compare ordinal
categorical variables such as education and income. For research
question two, the three key disparity variables (race, gender, and geo-
graphic area of residence) were ﬁrst analyzed with knowledge scores in
a bivariate manner, to determine if any had a signiﬁcant association.
Next, a multivariable model incorporating all three of the key disparity
variables was used to determine if any disparity variable was driving
the association compared to others. Finally, a multivariable model that
included the key disparity variables and demographic variables was
analyzed to determine if sociodemographic variables would attenuate
signiﬁcant associations between disparity variables and total knowl-
edge scores. For research question three, factorial ANOVA models were
performed to determine if there were signiﬁcant interaction eﬀects and
to determine if there was signiﬁcant moderation between the disparity
variables and demographic variables. Although various ﬁelds use
higher p-values for interaction terms, due to the lower power to detect a
signiﬁcant association, we considered a p-value of 0.05 to be a sig-
niﬁcant moderating association in order to prevent inﬂated type I error
rates. All analyses were conducted using p < 0.05 as the signiﬁcance
level.
4. Results
4.1. Sample description
A full description of participant sociodemographic and health status
characteristics is shown in Table 1. Participants (N=438) ranged in
age from 55 to 79 years (mean, 62.6 [SD 5.8]), and slightly more than
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half were female (57.3%; n=251). Participants were fairly evenly
distributed by race with 58.0% (n=254) White and 42.0% Black
(n=184). Slightly more than half lived in urban areas in the state of
Indiana (55.0%, n=241). Participants were mostly well educated with
60.7% (n=266) completing some college or higher. The average
number of years smoked was 37.6 (SD 8.8), and the average number of
packs of cigarettes smoked daily was 1.3 (SD 0.5).
4.2. Sociodemographic and health status characteristics associated with
lung cancer screening behavior
Key sociodemographic and health status characteristics that were
associated with screening behavior included race, geographic area of
residence, income, health insurance, and family history of lung cancer
(see Table 1). White participants were more likely to intend to screen or
to have been screened compared to Black participants (p=0.002).
When examining race by stage of adoption guided by the PAPM, race
was signiﬁcantly diﬀerent (p=0.0003). Black participants were una-
ware of lung cancer screening (54.8%, n=91) whereas White partici-
pants were more likely to intend to screen (73.9%, n=82). In addition,
participants who were unaware of lung cancer screening were mainly
comprised of participants living in urban areas (64.5%, n=107)
compared to those living in suburban (10.2%; n=17) and rural
(25.3%; n=42) areas. Similarly, individuals who reported being aware
of lung cancer screening but had never considered this screening option
for themselves mainly lived in urban areas (55.6%; n=25). Partici-
pants who reported they were undecided about lung cancer screening
were also more likely to live in urban areas (53.1%; n=26). Of those
who reported they intended to screen for lung cancer in the next six
months, the majority lived in rural areas (44.1%; n=49). However, of
those who had either had an LDCT to screen for lung cancer in the past
year and those who reported they were having annual scans, both were
Table 1
Sociodemographic and health status characteristics and lung cancer screening behavior.
Characteristics Total
sample
(n=438)
Screeners
(n=274)
Non-
screeners
(n=164)
p-Value
Mean age (continuous) 62.65
(5.76
62.12
(5.56)
62.96
(5.87)
0.141
Age (categorical) n (%)
55–64 years old 288 (65.8) 115 (70.1) 173 (63.1) 0.136
65 years or older 150 (34.2) 49 (29.9) 101 (36.9)
Sex n (%)
Male 187 (42.7) 65 (39.6) 122 (44.5) 0.317
Female 251 (57.3) 99 (60.4) 152 (55.5)
Race n (%)
White 254 (58.0) 111 (67.7) 143 (52.2) 0.002*
Black 184 (42.0) 53 (32.3) 131 (47.8)
Geographic Region n (%)
Urban 241 (55.0) 78 (47.6) 163 (59.5) 0.047*
Suburban 56 (12.8) 23 (14.0) 33 (12.0)
Rural 141 (32.2) 63 (38.4) 78 (28.5)
Education n (%)
Less than high school 40 (9.1) 11 (6.7) 29 (10.6) 0.188
High school graduate 132 (30.1) 46 (28.1) 86 (31.4)
Some college 144 (32.9) 60 (36.6) 84 (30.7)
College graduate or
higher
122 (27.9) 47 (28.7) 75 (27.4)
Income n (%)
<$25,000 236 (53.9) 78 (47.6) 158 (57.7) 0.026*
$25,000–$50,000 115 (26.3) 46 (28.1) 69 (25.2)
>$50,000 87 (19.9) 40 (24.4) 47 (17.2)
Health insurance n (%)
Government 279 (63.7) 86 (52.4) 193 (70.4) <0.001*
Private 120 (27.4) 54 (32.9) 66 (24.1)
Government+ Private 21 (4.8) 13 (7.9) 8 (2.9)
None 18 (4.1) 11 (6.7) 7 (2.6)
Smoking status n (%)
Current smoker 214 (48.9) 84 (51.2) 130 (47.5) 0.4444
Family history of lung
cancer n (%)
Yes 130 (29.7) 60 (36.6) 70 (25.6) 0.014*
Characteristics Total sample (n=438) Screeners (n=274) Non-screeners (n=164) p-Value
Mean (SD); Median (Range) Mean (SD); Median (Range) Mean (SD); Median (Range)
Pack-years tobacco smoking 48.16 (19.97); 40 (30–176) 47.98 (19.49); 40 (30–140) 48.28 (20.30); 40 (30–176) 0.879
Packs smoked daily 1.31 (0.53); 1 (0.5–5) 1.32 (0.52); 1 (0.75–4) 1.31 (0.54); 1 (0.5–5) 0.752
Years smoked 37.65 (8.76); 38 (15–65) 37.22 (8.60); 37 (15–60) 37.90 (8.87); 38.5 (15–65) 0.435
Years since quitting (n=223) 8.26 (4.76); 9 (0–17) 7.75 (4.87); 8.5 (0–15) 8.54 (4.69); 9 (0–17) 0.236
Age 62.65 (5.76); 61.5 (55–79) 62.12 (5.56); 61 (55–79) 62.96 (5.87); 62 (55–78) 0.141
Data collected between January and February 2017 from participants in the State of Indiana.
Values are frequency (percentage) for categorical variables and mean (standard deviation); median (range) for continuous variables. P-values were derived from Pearson Chi-Square tests
for categorical variables, Mantel-Haenszel 1 df Chi-Square test for ordinal variables (i.e. education and income), and Wilcoxon Rank-Sum tests for continuous variables.
p-values less than 0.05 are bolded to indicate statistical signiﬁcance.
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more likely to live in urban areas (63%; n=17 and 57.7%; n=15
respectively). There was a signiﬁcant diﬀerence in income between
participants who indicated they either intended to screen or had re-
cently completed lung cancer screening compared to those who had not
been screened (p= 0.026). Participants who had not been screened
reported annual income levels less than $25,000 (57.7%; n=158).
There was also a signiﬁcant diﬀerence between these two groups (i.e.,
screeners versus non-screeners) by insurance status (p < 0.001). Par-
ticipants with government-based health insurance in this study were
less likely to have been screened or intended to screen, mainly because
they were unaware of lung cancer screening (73.5%, n=122). Finally,
29.7% (n=130) of the total sample reported a family history of lung
cancer. Among those, there was a signiﬁcant diﬀerence between those
who reported intending to screen or having recently been screened
(36.6%; n=60) compared to those who had not been screened (25.6%;
n=70). There were no statistically signiﬁcant diﬀerences between
screeners and non-screeners by age, gender, education, or smoking
status noted.
4.3. Diﬀerences in knowledge of lung cancer risk and lung cancer screening
behavior by key disparity variables and sociodemographic characteristics
Total knowledge of lung cancer and screening scores were examined
by race, gender, geographic area of residence and other socio-
demographic variables and were associated with race and geographic
area of residence. Simple bivariate analyses revealed a signiﬁcant as-
sociation between total knowledge scores and race, with White parti-
cipants having slightly higher total knowledge scores (4.02 [0.10];
p < 0.001) compared to Black participants (3.19 [0.12]).
Geographically, participants living in suburban areas had the highest
total knowledge scores (p < 0.001) compared to rural and urban
participants. However, when all three disparity variables were included
in the model, only race remained signiﬁcant, with similar results; the
association of geographic area of residence with total knowledge scores
was attenuated (p=0.077), with suburban participants still retaining
the highest scores. This attenuation is not surprising, as in our data,
Black participants lived in urban areas at signiﬁcantly higher propor-
tions than White participants. Even after adjusting for socio-
demographic variables, race remained signiﬁcant, with White partici-
pants having higher total knowledge scores. Geographic area of
residence was no longer signiﬁcant, but education showed a signiﬁcant
association with total knowledge scores (p=0.014), with the highest
mean total knowledge score belonging to those with less than a high
school diploma, which was an unexpected ﬁnding, and the lowest mean
score to those with some college. As mentioned, although a signiﬁcant
diﬀerence was noted between the four groups (p=0.014), there was
very little variability across the total sample. Total knowledge scores
ranged from 0 to 9; those with less than a high school education had a
mean total knowledge score of 4.18 (0.20), high school graduates had a
mean total knowledge score of 3.51 (0.20), participants with some
college had a mean total knowledge score of 3.41 (0.31), and college
graduates had a mean total knowledge score of 3.90 (0.19). It is plau-
sible that marketing eﬀorts for lung screening during this time were
concentrated in more urban areas with higher numbers of participants
with less than a high school education. See Table 2.
4.4. Do sociodemographic and health status characteristics that are
associated with lung cancer screening behavior depend on race, gender, or
geographic area of residence?
Although there were marginally signiﬁcant interaction eﬀects be-
tween race and age (p=0.054) and between geographic area of re-
sidence and income (p=0.077), none of the factorial models reached
the necessary signiﬁcance level of 0.05 to be considered a signiﬁcant
moderating association.
5. Discussion
Consistent with ﬁndings in more established cancer screening pro-
grams (Burnett-Hartman et al., 2016; Lee et al., 2017; Peppercorn et al.,
2015), diﬀerences exist for lung cancer screening by race and geo-
graphic area of residence. Recent attention has been paid to the inﬂu-
ence of where an individual lives as a key social determinant of health
(World Health Organization, Commission on Social Determinants of
Health, n.d.; Secretary's Advisory Committee on Health Promotion and
Disease Prevention Objectives for 2020, 2010). Geographically, in this
study, urban residents were likely to be unscreened, and they were also
most likely to be unaware of screening. In order to be proactive in
addressing disparities in lung cancer screening behavior, it is critical to
identify where diﬀerences exist, but more importantly, why they exist.
Urban areas in the state of Indiana have the highest concentration of
facilities that perform lung cancer screening compared to rural areas
within the state. However, rural participants were more likely to be
screeners. It is possible there are other structural or perceived barriers
not assessed to explain this geographic disparity.
Race has historically been a proxy for multiple disparities evidenced
in the cancer care continuum, and reasons are multifactorial (i.e., so-
cioeconomic status, access to care, behavioral, education) (Fine et al.,
2005). In this study, racial disparities in the context of lung cancer
screening behavior highlight knowledge gaps with Black participants
having lower total knowledge scores than White participants. The range
of possible scores on the knowledge scale was 0 to 9 with higher scores
reﬂecting greater knowledge. Comparisons between groups revealed
Table 2
Sociodemographic characteristics by total knowledge scores (N=438).
Bivariate Adjusted for three main
predictors
Full model
Gender
Female 3.70 (0.10) 3.70 (0.12) 3.74 (0.18)
Male 3.64 (0.12) 3.73 (0.13) 3.77 (0.19)
p-value 0.734 0.819 0.838
Race
Black 3.19 (0.12) 3.32 (0.16) 3.48 (0.22)
White 4.02 (0.10) 4.11 (0.11) 4.02 (0.17)
p-value <0.001* <0.001* 0.005*
Geographic Region
Rural 3.81 (0.14) 3.51 (0.15) 3.54 (0.20)
Suburban 4.32 (0.22) 4.07 (0.22) 4.07 (0.27)
Urban 3.45 (0.11) 3.57 (0.11) 3.65 (0.18)
p-value <0.001* 0.077 0.123
Age
55–64 years 3.71 (0.18)
65+ years 3.79 (0.20)
p-value 0.556
Education
<High school 4.18 (0.20)
High school diploma 3.51 (0.20)
Some college 3.41 (0.31)
College graduate 3.90 (0.19)
p-value 0.014*
Income (annual)
< $25 k 3.92 (0.21)
$25–50 k 3.71 (0.24)
> $50 k 3.62 (0.21)
p-value 0.326
Insurance
Government 3.69 (0.14)
Private 3.65 (0.20)
None 3.19 (0.41)
Government &
private
4.48 (0.37)
p-value 0.106
Data collected between January and February 2017 from participants in the State of
Indiana.
Values are least square means (standard errors), with p-values from ANOVAs. Bivariate
analysis include each of the three predictors (gender, race, region) in separate models.
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low scores across both groups, but lower among Black participants
which is directly related to awareness. Black participants were more
likely to be unscreened for lung cancer primarily because they were
unaware of this relatively new screening test. Low levels of knowledge
in underrepresented individuals is a key barrier to cancer screening. If
an individual is unaware of a cancer screening option, there is increased
probability of a missed opportunity to engage in a discussion about that
screening. Further, if people are unaware of, or underestimate, their
personal risk of developing lung cancer, eligibility criteria for lung
cancer screening, or the process of screening itself, this may result in
lung cancer screening not being considered by a screening-eligible in-
dividual.
In 2015, CMS issued its national coverage determination for lung
cancer screening, which requires a shared decision-making and coun-
seling visit for reimbursement (Centers for Medicare & Medicaid
Services, n.d.). In addition to the beneﬁts and potential harms of lung
cancer screening, as screening continues to be implemented nation-
wide, it is essential that all screening-eligible individuals are educated
about risks for lung cancer, ways to reduce those risks (i.e., smoking
cessation, radon mitigation, decreasing occupational exposure) as well
as the option of screening for early detection. Of equal importance,
patient-clinician discussions about lung cancer screening oﬀer the op-
portunity to intervene with current smokers to assess stage of readiness
for a quit attempt. The lung cancer screening discussion can then serve
as a potentially teachable moment to intervene with, and help, current
smokers move toward smoking cessation (Brain et al., 2017). As lung
cancer screening implementation progresses forward, it will be essential
for screening programs to ensure all eligible individuals are aware of
the option to screen. More importantly, eﬀorts to increase awareness in
underrepresented and geographically dispersed patient populations is
critical in eﬀorts to both increase awareness of this new cancer
screening option, foster dialogue between patients and clinicians about
the option of screening, and decrease disparities in lung cancer
screening participation. As mentioned, the PAPM is a stage theory that
highlights the progression from being unaware (stage 1) of a health
behavior choice to action (stage 6) and maintenance (stage 7) (“The
Precaution Adoption Process Model” by Neil D. Weinstein, Peter M.
Sandman, and Susan J. Blalock, et al., 2008). A key stage that distin-
guishes the PAPM from other stage theories like the Transtheoretical
Model is a stage reﬂecting the decision not to act (stage 4) (“The
Precaution Adoption Process Model” by Neil D. Weinstein, Peter M.
Sandman, and Susan J. Blalock, et al., 2008). Therefore, to be
unscreened because an individual makes the decision to not be screened
after discussing the option with their clinician and weighing the risks
and beneﬁts before coming to an informed decision is very diﬀerent
than being unscreened because one is unaware of the option to screen.
Therefore, decision support interventions that support the patient and
clinician to engage in discussions about lung cancer screening that re-
sult in an informed decision are essential.
Lung cancer screening is still relatively new and the number of
screening-eligible individuals in the U.S. who have been screened is
low. As mentioned, in February 2017, Jemal and Fedewa noted, “of the
6.8 million smokers eligible for LDCT screening in 2015, only 262,700
received it”, equating to a 3.9% screening rate nationwide (Jemal &
Fedewa, 2017). Therefore, it is concerning that racial and geographic
disparities exist at this early stage. The most eﬀective treatment options
for lung cancer associated with the highest survival rates are for early
stage tumors. Screening to detect lung cancer at an early stage is critical
to decreasing mortality rates and the success of lung cancer screening
overall. It is important for the beneﬁt of early detection to be realized
for all eligible, and critical for patient education and outreach eﬀorts to
ensure equity across population groups in lung cancer screening.
6. Strengths and limitations
To our knowledge, this is the ﬁrst study to examine key variables
generally reﬂective of disparities (i.e., race, gender, and geographic
area of residence) in lung cancer screening behavior among screening-
eligible individuals. This study expands current knowledge on the
screening-eligible population by identifying sociodemographic and
health status characteristics that are associated with screening behavior
among racially and geographically diverse men and women. As men-
tioned previously, benchmarking variables associated with lung cancer
screening behavior as well as potential disparities is a critical pre-
requisite at this early stage of lung cancer screening to proactively
address equitable implementation of lung cancer screening.
As with all studies, this study is not without limitations. This study
involved screening-eligible individuals from the state of Indiana. While
Indiana has a relatively high smoking rate and thus sizable lung cancer
screening-eligible population, the results may not be generalizable to
other areas of the country. Further research is needed to examine racial,
gender, and geographic disparities on a national level to determine if
the ﬁndings of this study extend nationwide or if there are other vari-
ables that are more salient in other geographic areas of the country.
Because lung cancer screening is still nascent, individuals in Stage 5
(intending to screen) are larger than those in Stages 6 (having recently
been screened) and 7 (screening annually). This study was limited
statistically by low participant numbers in Stage 5. Although intent has
been used in other studies as proxies for behavior (Ajzen et al., 2004),
this is not always a reliable proxy and intending to screen is diﬀerent
from actual behavior. As lung screening implementation grows na-
tionwide, it is important to replicate disparities-focused studies to ex-
amine potential diﬀerences between intention and behavior. In addi-
tion, although being able to identify individuals at their current stage of
adoption for the decision to screen, or not, for lung cancer is incredibly
important, most screening-eligible individuals remain unaware lung
cancer screening exists. This limits our statistical capabilities beyond
descriptive analyses by stage. As lung screening becomes more widely
implemented and awareness increases, it is essential that potential
disparities in screening behavior are examined to identify persistence
and trends. The current study provides a baseline at a relatively new
stage of lung cancer screening implementation on which to benchmark
future results. Finally, we did not deﬁne insurance status beyond gov-
ernment-based, private, government-based plus supplement, and un-
insured. Future studies examining diﬀerences by speciﬁc insurance
types are warranted to fully understand lung screening behavior.
7. Conclusion
Lung cancer screening has the potential to decrease lung cancer-
related mortality in appropriate, high-risk individuals. However, in-
dividuals need to be aware of this screening option, be engaged in a
discussion with an informed clinician, and if the decision is to screen,
structural, logistical and perceived barriers need to be addressed. We
have a unique opportunity at this relatively early stage of lung cancer
screening implementation to learn from previous screening im-
plementation in other cancers as well as from our target patient po-
pulation as to what variables inﬂuence screening behavior. This
knowledge can be used to design equitable patient outreach programs,
meaningful patient engagement materials, and eﬀective decision sup-
port for patients and clinicians.
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